Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 80
Filtrar
1.
An. bras. dermatol ; 99(1): 57-65, Jan.-Feb. 2024. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1527712

RESUMO

Abstract Background: One of the main adverse reactions of adjuvant radiotherapy for breast cancer is radiodermatitis. Objective: To assess the incidence of radiodermatitis in women with breast cancer, identify factors associated with its severity and determine the time at which this event occurs. Methods: Prospective cohort study in 113 women with breast cancer who were evaluated before radiotherapy and at every fifth session until the end of treatment. Logistic regression and Cox proportional regression model were used for the assessment of risk factors; P values < 0.05 were considered significant. Results: The incidence rate of radiodermatitis was 98.2% and it was demonstrated that for each additional point of the Body Mass Index (BMI), the chance of occurrence of grades II to IV radiodermatitis increases by 14% (OR = 1.14 [95% CI 1.04-1.26]; p = 0.004) and statin use increases the risk of more severe skin lesions by four-fold (OR = 4.27 [95% CI 1.11-16.42]; p = 0.035). The exclusive use of hydrogel for skin hydration was an independent factor in delaying the onset of radiodermatitis (HR = 0.55 [95% CI 0.36-0.82]; p = 0.004). Study limitations: The main limitation of this study was its external validity. The identified factors should be considered for services and populations similar to those in this study. Conclusions: There was a high incidence of radiodermatitis and its severity was related to higher BMI, statin use; there was a protective effect of hydrogel use.

2.
An Bras Dermatol ; 99(1): 57-65, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-37657957

RESUMO

BACKGROUND: One of the main adverse reactions of adjuvant radiotherapy for breast cancer is radiodermatitis. OBJECTIVE: To assess the incidence of radiodermatitis in women with breast cancer, identify factors associated with its severity and determine the time at which this event occurs. METHODS: Prospective cohort study in 113 women with breast cancer who were evaluated before radiotherapy and at every fifth session until the end of treatment. Logistic regression and Cox proportional regression model were used for the assessment of risk factors; P values < 0.05 were considered significant. RESULTS: The incidence rate of radiodermatitis was 98.2% and it was demonstrated that for each additional point of the Body Mass Index (BMI), the chance of occurrence of grades II to IV radiodermatitis increases by 14% (OR=1.14 [95% CI 1.04-1.26]; p=0.004) and statin use increases the risk of more severe skin lesions by four-fold (OR=4.27 [95% CI 1.11-16.42]; p=0.035). The exclusive use of hydrogel for skin hydration was an independent factor in delaying the onset of radiodermatitis (HR=0.55 [95% CI 0.36-0.82]; p=0.004). STUDY LIMITATIONS: The main limitation of this study was its external validity. The identified factors should be considered for services and populations similar to those in this study. CONCLUSIONS: There was a high incidence of radiodermatitis and its severity was related to higher BMI, statin use; there was a protective effect of hydrogel use.


Assuntos
Neoplasias da Mama , Inibidores de Hidroximetilglutaril-CoA Redutases , Radiodermatite , Humanos , Feminino , Radiodermatite/epidemiologia , Radiodermatite/etiologia , Incidência , Estudos de Coortes , Estudos Prospectivos , Neoplasias da Mama/radioterapia , Hidrogéis
3.
Artigo em Inglês | MEDLINE | ID: mdl-38116955

RESUMO

The standard of care for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) involves excision by conventional surgery (CS) with a predefined safety margin of resection or micrographic surgery (MS) with microscopic margin control. Previous studies have reported the superiority of MS in reducing recurrences for high-risk BCC and SCC. This systematic review aimed to assess MS and CS recurrence rates by including randomized clinical trials (RCTs) and cohort studies. A systematic review and meta-analysis were conducted for related studies in PubMed, LILACS, Embase, Scopus, Web of Science, CINHAL and Cochrane until May 2023. RCTs and cohorts involving patients with BCC or SCC submitted to MS and CS were included. Risk of bias assessment followed Cochrane-recommended tools for RCTs and cohorts, and certainty of evidence followed the GRADE approach. Pooled estimates were used to determine the relative risk (RR) and absolute risk difference (RD) using a random-effects model. Seventeen studies were included, two RCTs and fifteen cohorts. There were 82 recurrences in 3050 tumours submitted to MS, with an overall recurrence rate of 3.1% (95% CI 2.0%-4.7%). For CS, there were 209 recurrences in 3453 tumours, with a recurrence rate of 5.3% (95% CI 2.9%-9.3%). The combined estimate of RR was 0.48 (95% CI 0.36-0.63), without heterogeneity nor evidence of publication bias (p > 0.3). The RD resulted in 2.9% (95% CI 1.0%-4.9%; NNT = 35). Regarding subgroup analysis, the RR for BBC was 0.37 (95% CI 0.25-0.54), and RD was 3.7% (95% CI 0.8%-6.5%; NNT = 28). For SCC, RR was 0.57 (95% CI 0.29-1.13), and RD was 1.9% (95% CI 0.8%-4.7%; NNT = 53). Among primary tumours, RR was 0.39 (95% CI 0.28-0.54), and for recurrent tumours was 0.67 (95% CI 0.30-1.50). There is moderate evidence based on two RCTs, and low evidence based on 15 cohort studies that MS is superior to CS in reducing recurrences of BCCs and primary tumours. The development of protocols that maximize the cost-effectiveness of each method in different clinical scenarios is paramount.

10.
An. bras. dermatol ; 97(2): 157-165, Mar.-Apr. 2022. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1374232

RESUMO

Abstract Background Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK). Objectives Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical formulation of antioxidants versus placebo in the treatment of advanced photodamage. Methods This was a randomized, double-blind, factorial clinical trial. Participants with AKs on their forearms were randomized to apply regular sunscreen (SC) or sunscreen with photolyase (SC+P) on both forearms during the day. One of the forearms in each group was randomized again to receive topical antioxidants (AOx), and the other forearm received a placebo cream (both for night application). The four groups were SC/AOx, SC/placebo, SC+P/AOx, and SC+P/placebo. The duration of treatment was 8 weeks. Primary outcomes were total AK clearance, decrease in Forearm Photoaging Scale (FPS), and AK severity scores. Secondary outcomes were reduction in AK count, partial clearance rate, and safety. Results Forty participants (80 forearms) were included. All groups showed significant improvement in outcomes at week eight. There were no significant differences between SC and SC+P for either outcome. AOx led to a significant reduction in AK count (22%; p < 0.05). Partial clearance was obtained in 18 (47.4%) forearms treated with AOx and in 9 (23.7%) treated with placebo (p < 0.05). All groups reduced the FPS score, without significant differences among them. Conclusions There is no difference in the treatment of advanced photodamage skin when comparing the use of sunscreen with photolyase and regular sunscreen, and topical antioxidants were more efficient in reducing AK count than placebo. Study limitations Short interval of follow-up and absence of re-evaluation in the absence of treatment were limitations of the present study.

11.
Nursing (Ed. bras., Impr.) ; 25(287): 7606-7617, abr.2022. tab
Artigo em Inglês, Português | LILACS, BDENF - Enfermagem | ID: biblio-1372529

RESUMO

Objetivo: avaliar o desenvolvimento de lesão por pressão em profissionais de saúde desencadeadas pelas máscaras de proteção individual N95, assim como avaliar o uso de barreiras de proteção usadas como interface para prevenção desse tipo de lesão. Método: Trata-se de um estudo transversal desenvolvido de julho de 2020 a julho de 2021. Para a coleta de dados, foi aplicado questionário para avaliar as particularidades da pele, desenvolvimento de lesão, classificação e os fatores de risco para seu desenvolvimento. Para análise estatística foi considerada a significância de p <0,1 e regressão logística múltipla. Resultados: Foram avaliados 85 profissionais, sendo que 91,8% destes apresentaram algum tipo de lesão. Conclusão: Conclui-se que a lesão por pressão relacionada ao uso de máscaras de proteção individual N95 apresentou alta ocorrência nessa população. E embora importantes, barreiras protetoras foram pouco utilizadas devido a questões financeiras da instituição(AU)


Objective: to evaluate the development of pressure injuries triggered by N95 personal protective masks in health professionals, as well as to evaluate the use of protective barriers used as an interface to prevent this type of injury. Method: This is a cross-sectional study developed from July 2020 to July 2021. For data collection, a questionnaire was applied to assess the particularities of the skin, lesion development, classification and risk factors for its development. For statistical analysis, significance of p <0.1 and multiple logistic regression were considered. Results: Eighty-five professionals were evaluated, and 91.8% of them developed some type of injury. Conclusion: Pressure injuries related to the use of N95 personal protective masks were highly prevalent in this population. And although important, protective barriers were under-used due to financial issues in the institution(AU)


Objetivo: evaluar el desarrollo de lesiones por presión en profesionales de la salud provocadas por máscaras de protección personal N95, así como evaluar el uso de barreras protectoras utilizadas como interfaz para prevenir este tipo de lesión. Método: Se trata de un estudio transversal desarrollado de julio de 2020 a julio de 2021. Para la recolección de datos se aplicó un cuestionario para evaluar las particularidades de la piel, desarrollo de la lesión, clasificación y factores de riesgo para su desarrollo. Para el análisis estadístico se consideró la significación de p < 0,1 y la regresión logística múltiple. Resultados: Se evaluaron 85 profesionales, de los cuales el 91,8% presentaba algún tipo de lesión. Conclusión: Se concluye que las lesiones por presión relacionadas con el uso de máscaras de protección personal N95 fueron altamente prevalentes en esta población. Y aunque importantes, las barreras de protección fueron poco utilizadas por cuestiones financieras de la institución.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Adulto Jovem , Lesão por Pressão/etiologia , Respiradores N95/efeitos adversos , COVID-19/prevenção & controle , Estudos Transversais , Inquéritos e Questionários
12.
An Bras Dermatol ; 97(2): 157-165, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35039206

RESUMO

BACKGROUND: Several treatments are available for skin with advanced photodamage, which is characterized by the presence of actinic keratoses (AK). OBJECTIVES: Evaluate the efficacy of using sunscreen with photolyase compared to regular sunscreen, as well as to compare the combination of a topical formulation of antioxidants versus placebo in the treatment of advanced photodamage. METHODS: This was a randomized, double-blind, factorial clinical trial. Participants with AKs on their forearms were randomized to apply regular sunscreen (SC) or sunscreen with photolyase (SC+P) on both forearms during the day. One of the forearms in each group was randomized again to receive topical antioxidants (AOx), and the other forearm received a placebo cream (both for night application). The four groups were SC/AOx, SC/placebo, SC+P/AOx, and SC+P/placebo. The duration of treatment was 8 weeks. Primary outcomes were total AK clearance, decrease in Forearm Photoaging Scale (FPS), and AK severity scores. Secondary outcomes were reduction in AK count, partial clearance rate, and safety. RESULTS: Forty participants (80 forearms) were included. All groups showed significant improvement in outcomes at week eight. There were no significant differences between SC and SC+P for either outcome. AOx led to a significant reduction in AK count (22%; p < 0.05). Partial clearance was obtained in 18 (47.4%) forearms treated with AOx and in 9 (23.7%) treated with placebo (p < 0.05). All groups reduced the FPS score, without significant differences among them. CONCLUSIONS: There is no difference in the treatment of advanced photodamage skin when comparing the use of sunscreen with photolyase and regular sunscreen, and topical antioxidants were more efficient in reducing AK count than placebo. STUDY LIMITATIONS: Short interval of follow-up and absence of re-evaluation in the absence of treatment were limitations of the present study.


Assuntos
Desoxirribodipirimidina Fotoliase , Ceratose Actínica , Antioxidantes/uso terapêutico , Desoxirribodipirimidina Fotoliase/uso terapêutico , Humanos , Ceratose Actínica/tratamento farmacológico , Protetores Solares/uso terapêutico , Resultado do Tratamento
14.
Syst Rev ; 10(1): 294, 2021 11 04.
Artigo em Inglês | MEDLINE | ID: mdl-34736537

RESUMO

BACKGROUND: Despite the expectations regarding the effectiveness of chloroquine (CQ) and hydroxychloroquine (HCQ) for coronavirus disease (COVID-19) management, concerns about their adverse events have remained. OBJECTIVES: The objective of this systematic review was to evaluate the safety of CQ and HCQ from malarial and non-malarial randomized clinical trials (RCTs). METHODS: The primary outcomes were the frequencies of serious adverse events (SAEs), retinopathy, and cardiac complications. Search strategies were applied to MEDLINE, EMBASE, LILACS, CENTRAL, Scopus, and Trip databases. We used a random-effects model to pool results across studies and Peto's one-step odds ratio (OR) for event rates below 1%. Both-armed zero-event studies were excluded from the meta-analyses. We used the Grading of Recommendations Assessment, Development, and Evaluation system to evaluate the certainty of evidence. RESULTS: One hundred and six RCTs were included. We found no significant difference between CQ/HCQ and control (placebo or non-CQ/HCQ) in the frequency of SAEs (OR: 0.98, 95% confidence interval [CI]: 0.76-1.26, 33 trials, 15,942 participants, moderate certainty of evidence). However, there was a moderate certainty of evidence that CQ/HCQ increases the incidence of cardiac complications (RR: 1.62, 95% CI: 1.10-2.38, 16 trials, 9908 participants). No clear relationship was observed between CQ/HCQ and retinopathy (OR: 1.63, 95% CI: - 0.4-6.57, 5 trials, 344 participants, very low certainty of evidence). CONCLUSIONS: CQ and HCQ probably do not increase SAEs, with low frequency of these adverse events on malarial and non-malarial conditions. However, they may increase cardiac complications especially in patients with COVID-19. No clear effect of their use on the incidence of retinopathy was observed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020177818.


Assuntos
Tratamento Farmacológico da COVID-19 , Hidroxicloroquina , Cloroquina/efeitos adversos , Humanos , Hidroxicloroquina/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto , SARS-CoV-2
17.
An. bras. dermatol ; 96(3): 346-348, May-June 2021. graf
Artigo em Inglês | LILACS | ID: biblio-1285064

RESUMO

Abstract Paracoccidioidomycosis is an endemic systemic mycosis caused by Paracoccidioides brasiliensis complex and P. lutzii. It is a rare disease in non-HIV-induced immunosuppressed individuals. In organ transplant recipients, it is more frequently associated with immunosuppression after kidney transplantation. In a liver transplant patient, only one case has been published in the literature to date. The present report comprises the case of a 47-year-old female patient with disseminated skin lesions associated with signs and symptoms of systemic involvement of paracoccidioidomycosis that manifested one year after liver transplantation and under an immunosuppression regimen with tacrolimus and mycophenolate mofetil.


Assuntos
Humanos , Feminino , Paracoccidioides , Paracoccidioidomicose/diagnóstico , Paracoccidioidomicose/diagnóstico por imagem , Transplante de Rim , Transplante de Fígado/efeitos adversos , Transplantados , Pessoa de Meia-Idade
19.
Rev Lat Am Enfermagem ; 29: e3424, 2021.
Artigo em Inglês, Português, Espanhol | MEDLINE | ID: mdl-33852689

RESUMO

OBJECTIVE: to describe the methodological process of cultural adaptation of the Glamorgan Scale to Brazilian Portuguese. METHOD: a methodological study of translation and cultural adaptation of the Glamorgan Scale, following the six stages: initial translation, synthesis of translations, back-translation, committee of experts, pre-test, and submission of the adapted version to the author for approval. The committee of experts was composed of five physicians and, during evaluation, a semantic, idiomatic, cultural and conceptual analysis was carried out. The agreement and representativeness of the items were assessed using the Content Validity Index. A minimum value of 80% agreement was considered. RESULTS: all stages of the translation and cross-cultural adaptation process were satisfactory. In the evaluation made by the committee of experts, all items obtained an agreement greater than 80% in the first evaluation round. The pre-test stage allowed for a critical overview of the instrument, where few modifications were suggested by the participants. CONCLUSION: the Glamorgan Scale was translated and culturally adapted to Brazilian Portuguese. Future psychometric studies are necessary to validate the scale.


Assuntos
Comparação Transcultural , Pediatria , Lesão por Pressão , Criança , Humanos , Brasil , Inquéritos e Questionários , Traduções
20.
An Bras Dermatol ; 96(3): 346-348, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33775484

RESUMO

Paracoccidioidomycosis is an endemic systemic mycosis caused by Paracoccidioides brasiliensis complex and P. lutzii. It is a rare disease in non-HIV-induced immunosuppressed individuals. In organ transplant recipients, it is more frequently associated with immunosuppression after kidney transplantation. In a liver transplant patient, only one case has been published in the literature to date. The present report comprises the case of a 47-year-old female patient with disseminated skin lesions associated with signs and symptoms of systemic involvement of paracoccidioidomycosis that manifested one year after liver transplantation and under an immunosuppression regimen with tacrolimus and mycophenolate mofetil.


Assuntos
Transplante de Rim , Transplante de Fígado , Paracoccidioides , Paracoccidioidomicose , Feminino , Humanos , Transplante de Fígado/efeitos adversos , Pessoa de Meia-Idade , Paracoccidioidomicose/diagnóstico , Paracoccidioidomicose/tratamento farmacológico , Transplantados
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...